Search Results - Ajay Major

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study by Hira Mian, Tanya M. Wildes, Ravi Vij, Matthew J. Pianko, Ajay Major, Mark A. Fiala

    Published in Blood Cancer Journal (2023-05-01)
    Get full text
    Article


  2. 2

    Frontline polatuzumab vedotin for diffuse large B‐cell lymphoma: A survey of clinician impressions by Ajay Major, Edward R. Scheffer Cliff, Daniel A. Ermann, Urshila Durani, David A. Russler‐Germain

    Published in eJHaem (2022-08-01)
    Get full text
    Article


  3. 3

    Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) by Benjamin A. Derman, Ajay Major, Jennifer Cooperrider, Ken Jiang, Aubrianna Ramsland, Theodore Karrison, Tadeusz Kubicki, Andrzej J. Jakubowiak

    Published in Blood Cancer Journal (2024-10-01)
    Get full text
    Article


  4. 4

    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant by Benjamin A. Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E. Avigan, Murtuza Rampurwala, David Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej J. Jakubowiak

    Published in Blood Cancer Journal (2024-05-01)
    Get full text
    Article


  5. 5

    Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas by Ajay Major, Justin Kline, Theodore G. Karrison, Paul A. S. Fishkin, Amy S. Kimball, Adam M. Petrich, Sreenivasa Nattam, Krishna Rao, Bethany G. Sleckman, Kenneth Cohen, Koen van Besien, Aaron P. Rapoport, Sonali M. Smith

    Published in Haematologica (2021-07-01)
    Get full text
    Article


  6. 6

    Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/aza... by Amanda C. Winters, Mohd Minhajuddin, Brett M. Stevens, Ajay Major, Grace Bosma, Diana Abbott, Nicholas Miltgen, Ji Yuan, Amy L. Treece, Bradford J. Siegele, Mark D. Ewalt, Jonathan A. Gutman, Craig T. Jordan, Daniel A. Pollyea

    Published in Haematologica (2023-12-01)
    Get full text
    Article


  7. 7

    Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet‐treated multiple myeloma without transplant by Benjamin A. Derman, Jennifer Cooperrider, Anna Pula, Heidi Simmons, Tadeusz Kubicki, Jeffrey Zonder, Aimaz Afrough, David Grinblatt, Jacalyn Rosenblatt, Larry D. Anderson Jr., Andrew Kin, David Avigan, Sunil Narula, Shayan Rayani, Ken Jiang, Ajay Major, Theodore Karrison, Allison Jacob, Andrzej J. Jakubowiak

    Published in HemaSphere (2025-08-01)
    Get full text
    Article


  8. 8

    Factors associated with health-related quality of life and financial toxicity among gynecological cancer patients in Southern Nigeria by Chibuzor F. Ogamba, Adedayo Joseph, Ayodeji Kayode Adefemi, Chidike Onyedikachi Ezegwui, Ajay Major, Rasaq Oluwagbemiga Jimoh, Michael Osahumen Orhue, Michael Chudi Ezeanochie, Boniface Uji Ago, Linda Ogochukwu Amah, Emeka Emmanuel Okoh, Courage Osamudiamen Idahor, Mazpa Ejikem, Alexander Clive Tinworth, Charilaos Zisou, Nwamaka N. Lasebikan

    Published in Scientific Reports (2025-07-01)
    Get full text
    Article


  9. 9

    Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers by Timothy J. Voorhees, Eric M. McLaughlin, Pallawi Torka, Jorge Florindez, Na Hyun Kim, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish Ayyappan, Lauren Shea, Matt Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal Desai, Praveen Ramakrishnan Geethakumari, Mehdi Hamadani, Natalie Grover, Narendranath Epperla

    Published in Blood Cancer Journal (2025-03-01)
    Get full text
    Article


Search Tools: